AURINIA PHARMACEUTICALS
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.
AURINIA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.auriniapharma.com
Total Employee:
251+
Status:
Active
Contact:
+1 (250) 744-2487
Email Addresses:
[email protected]
Total Funding:
658.46 M USD
Technology used in webpage:
Nginx JsDelivr Common Name Invalid Amazon S3 Ruby On Rails Token OSS CDN GoDaddy SSL Squarespace Hosted CenturyLink
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Innate Biologics
Innate Biologics offers tissue-targeted anti-inflammatory treatment to patients suffering from conditions and diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Vividion Therapeutics
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-02-05 | Isotechnika Pharma | Isotechnika Pharma acquired by Aurinia Pharmaceuticals | N/A |
Investors List
Apple Tree Partners
Apple Tree Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
Redmile Group
Redmile Group investment in Post-IPO Equity - Aurinia Pharmaceuticals
ILJIN Life Science
ILJIN Life Science investment in Post-IPO Equity - Aurinia Pharmaceuticals
Difference Capital
Difference Capital investment in Post-IPO Equity - Aurinia Pharmaceuticals
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Aurinia Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Aurinia Pharmaceuticals
venBio Partners
venBio Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
Official Site Inspections
http://www.auriniapharma.com Semrush global rank: 3.26 M Semrush visits lastest month: 4.43 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Aurinia Pharmaceuticals"
ABOUT US - Aurinia Pharmaceuticals Inc.
For inquiries related to strategic partnerships, please contact us at [email protected]. In 2020, Aurinia entered into a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. for the development and …See details»
Company Information :: Aurinia Pharmaceuticals Inc. (AUPH)
[email protected]. General inquiries can also be sent to [email protected]. Company Contact Aurinia Pharmaceuticals Inc. #140, 14315 – 118 Avenue Edmonton, AB …See details»
Aurinia Pharmaceuticals Inc. Announces New CEO and Board …
Apr 11, 2019 On behalf of the entire board and organization, I would like to thank Dr. Glickman for all of his efforts and contributions that have brought Aurinia to where it is today. As we wish …See details»
Aurinia Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 (250) 744-2487 Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and …See details»
Aurinia Pharmaceuticals Inc. | LinkedIn
Aurinia Pharmaceuticals Inc. | 26,487 followers on LinkedIn. We pursue promising science to address some of the toughest challenges in autoimmune disease. Community guidelines: 1. …See details»
Aurinia Pharmaceuticals Inc. | LinkedIn
Aurinia Pharmaceuticals Inc. | 26,439 followers on LinkedIn. We pursue promising science to address some of the toughest challenges in autoimmune disease. Community guidelines: 1. By posting to ...See details»
Company Description - Stock Analysis
Jan 26, 1999 Ticker Symbol: AUPH: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001600620: CUSIP Number: 05156V102: ISIN …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 25, 2024 View Aurinia Pharmaceuticals (www.auriniapharma.com) location in Alberta, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Aurinia Pharmaceuticals Company Profile | Management and
Www.auriniapharma.com Aurinia Pharmaceuticals Profile and History Founded in 2012, Aurinia Pharmaceuticals a clinical-stage biopharmaceutical company develops and commercializes …See details»
Management Team :: Aurinia Pharmaceuticals Inc. (AUPH)
Before Cerecor, Joe was the Vice President of Finance at Sucampo Pharmaceuticals Inc., where he was responsible for building out the finance organization to effectively support the …See details»
Aurinia Pharmaceuticals Inc. (AUPH) - Yahoo Finance
Find the latest Aurinia Pharmaceuticals Inc. (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Careers | Aurinia Careers
At Aurinia, our mission and vision are our north star, directing all that we to do to better patient health and well-beingSee details»
Aurinia Pharmaceuticals - Craft
Oct 29, 2024 Aurinia Pharmaceuticals has 5 employees across 4 locations and $175.51 m in annual revenue in FY 2023. See insights on Aurinia Pharmaceuticals including office locations, …See details»
Company Profile for Aurinia Pharmaceuticals Inc.
Feb 6, 2015 Type of Organization: Public Industry: Pharmaceutical Key Executives: CEO: Stephen Zaruby COO: Michael Martin CFO: Dennis Bourgeault Investor Relations. Contact: …See details»
Aurinia Acquires Novel Pipeline Assets Targeting ... - Business Wire
Aug 17, 2021 Media: Dana Lynch Corporate Communications, Aurinia [email protected] Contacts Investors: Glenn Schulman, PharmD, MPH Investor …See details»
Aurinia Reports Fourth Quarter and Full Year 2020 Financial …
Feb 24, 2021 The primary driver for the decrease of $2.5 million in R&D spend in 2020 was a decrease in drug manufacturing and supply costs, lower Contract Research Organization …See details»
Working at Aurinia Pharmaceuticals - Zippia
Www.auriniapharma.com. Organization Type. Public. Social Media. Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing …See details»
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months …
Nov 7, 2024 This press release is intended to be read in conjunction with the Company’s unaudited condensed consolidated financial statements and Management's Discussion and …See details»
Aurinia Reports Fourth Quarter and Full Year 2022 Financial …
Dec 31, 2022 Aurinia will host a conference call and webcast to discuss the quarter and year ended December 31, 2022 financial results today, Tuesday, February 28, 2023 at 8:30 a.m. …See details»